Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10,915,750
-
Number of holders
-
270
-
Total 13F shares, excl. options
-
9,730,211
-
Shares change
-
-250,621
-
Total reported value, excl. options
-
$2,062,202,677
-
Value change
-
-$49,579,570
-
Put/Call ratio
-
2.44%
-
Number of buys
-
115
-
Number of sells
-
-146
-
Price
-
$211.82
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q1 2021
319 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q1 2021.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 270 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,730,211 shares
of 10,915,750 outstanding shares and own 89.14% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,813,853 shares), VANGUARD GROUP INC (1,403,054 shares), RENAISSANCE TECHNOLOGIES LLC (894,410 shares), RICE HALL JAMES & ASSOCIATES, LLC (383,034 shares), DIMENSIONAL FUND ADVISORS LP (381,465 shares), STATE STREET CORP (355,502 shares), Bank of New York Mellon Corp (215,412 shares), PRINCIPAL FINANCIAL GROUP INC (202,286 shares), GEODE CAPITAL MANAGEMENT, LLC (188,509 shares), and NORTHERN TRUST CORP (146,163 shares).
This table shows the top 270 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.